Bruce Hough, Maher Albitar Clinical Lymphoma, Myeloma and Leukemia, Vol. 000, No.xxx, 1–3 © 2025 Published by Elsevier Inc. Keywords: CD19 dim, Diffuse large b-cell
Aishwarya Sridhar1 · Dylon Patel1 · Alexandra Della Pia2 · Tatyana A. Feldman2,3 · Lori A. Leslie2,3 · Andre H. Goy1,2 · Maher Albitar4 · Andrew Ip2,3Received: 27 June 2024 / Accepted: 19 November 2024© The Author(s) 2024 OPEN AbstractBackground CD19-directed chimeric antigen receptor
Andrew Ip 1,2,*,† , Maciej Kabat 3,† , Lindsay Fogel 1,4 , Hassan Alkhatatneh 5 , Jason Voss 2, Amolika Gupta 4,6,Alexandra Della Pia 2
The research addresses the challenge of disease relapse, a primary cause of treatment failure post-hematopoietic stem cell transplantation. By employing next-generation sequencing of cfDNA to monitor donor cell chimerism and minimal residual disease (MRD) early after transplantation, the study identifies patients at increased risk of relapse. This approach allows for potential early intervention with consolidation therapy, aiming to mitigate the risk of treatment failure.
GTC presented abstracts at ASH 2024 GTC’s posters from 2024 Convention of American Society of Hematology are now available to be downloaded. Please reach out
Just published in The Journal of Liquid Biopsy Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic
Maher Albitar, Ahmad Charifa, Sally Agersborg, Andrew Pecora, Andrew Ip, Andre Goy Abstract: Most of the current utilization of liquid biopsy (LBx) is based on
New publication in New England Journal of Medicine for Genomic Testing Cooperative (GTC). GTC work was in collaboration with Dana-Faber cancer Institute/Harvard Medical School, Georgetown
New Paper in Journal of Clinical Pathways GTC has participated in a new paper titled: Bringing Value to Health Care. Read the paper as it
GTC presented abstracts at ASCO 2024 GTC’s posters from 2024 Convention of American Society of Clinical Oncology are now available to be downloaded. Please reach
